Anti-tumour effect of the fourth-generation chimeric antigen receptor T cells targeting CD133 against cholangiocarcinoma cells-Reference-Cited by-同舟云学术

Anti-tumour effect of the fourth-generation chimeric antigen receptor T cells targeting CD133 against cholangiocarcinoma cells

Published:2020-12 Issue: Volume:89 Page:107069
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Sangsuwannukul Thanich,Supimon Kamonlapat,Sujjitjoon Jatuporn,Phanthaphol Nattaporn,Chieochansin Thaweesak,Poungvarin Naravat,Wongkham Sopit,Junking Mutita,Yenchitsomanus Pa-thai

Funder

Faculty of Medicine Siriraj Hospital, Mahidol University

Mahidol University

Thailand Research Fund

International Research Network

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference64 articles.

1. Forty‐year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise;Saha;Oncologist,2016

2. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma;Bertuccio;J. Hepatol.,2019

3. Cholangiocarcinoma: a guide for the nonspecialist;Alsaleh;Int. J. Gen. Med.,2018

4. Cholangiocarcinoma;Khan;Surg. Clin. North Am.,2019

5. Ablative therapy for unresectable intrahepatic cholangiocarcinoma: a systematic review and meta-analysis;Yousaf;J. Clin. Exp. Hepatol.,2019

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy;Hematology/Oncology Clinics of North America;2024-06

2. Cytotoxicity of fourth-generation anti-Trop2 CAR-T cells against breast cancer;International Immunopharmacology;2024-03

3. Molecular Biomarkers and Signaling Pathways of Cancer Stem Cells in Colorectal Cancer;Technology in Cancer Research & Treatment;2024-01

4. Igniting cold tumors of intrahepatic cholangiocarcinoma: An insight into immune evasion and tumor immune microenvironment;The Innovation Medicine;2024

5. Challenges and opportunities for treating intrahepatic cholangiocarcinoma: targeted therapy;Hepatoma Research;2023-12-31